Search results
FDA Tells Vaccine Makers to Target New COVID Variant for Fall
Wyoming Tribune-Eagle· 3 hours agoCOVID vaccine makers will be advised to update their shots to target the KP.2 variant, an offshoot...
Is It Too Late to Buy Novavax Stock?
Motley Fool via Yahoo Finance· 5 hours agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider when...Stock Advisor provides investors with an...
COVID summer guide: How to navigate symptoms, variants and vaccines this season
Yahoo Life· 18 hours agoYounger children, adults 65 and older and immunocompromised people may need multiple doses, the...
Two shots in one? Moderna's COVID-19 and flu vaccine reports favorable results
USA Today· 4 days agoModerna said Monday that its combination vaccine against flu and COVID-19 drew a greater immune...
The FDA tells Covid-19 vaccine makers to update shot to target the variant currently in circulation
KEYT 3 Santa Barbara· 7 days agoThe FDA’s committee of independent advisers voted unanimously Wednesday to recommend that the agency...
KP.3 is the dominant COVID-19 variant in the US: Latest on test positivity, deaths, symptoms
USA TODAY via Yahoo News· 19 hours agoDuring the Vaccines and Related Biological Products Advisory Committee, health experts from vaccine manufacturers Pfizer, Moderna and Novavax< ...
New COVID Vaccines Targeting JN.1 Will Arrive This Fall
Verywell Health via Yahoo News· 7 days agoThe influenza vaccine, for instance, is updated annually. Jetelina said that people may be more...
FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
WUSF 89.7· 6 days agoGovernment advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines...
Bull Market and Beyond: 3 Stocks Just Waiting to Soar
The Motley Fool via AOL· 3 days agoThe 10 stocks that made the cut could produce monster returns in the coming years. Consider...
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June...
Benzinga· 5 days agoMid-cap stocks saw significant gains last week, with top performers like AGIO, VRNT, and NVAX,...